Newborn Solutions is a medical device startup that will enable non-invasive detection and monitoring of infections in serous body fluids, with an initial and primary focus on infant meningitis. Meningitis detection is challenging due to the unspecific signs associated to the infection, such as fever of unknown source, particularly in young infants and newborns with very little symptomatology. That’s why history and physical examination alone are often insufficient to confirm or exclude the diagnosis. Lumbar puncture to draw a sample of cerebrospinal fluid is an essential investigation, but difficult to perform and potentially hazardous for the sick child. Neosonics, the medical device we are developing, will be used to confirm accurate suspicion of meningitis and to provide a better care and management of neonatal and infant at risk or confirmed meningitis. Neosonics, is based on artificial intelligence algorithms to automatically count, at the push of a button, white blood cells in the cerebrospinal fluid directly below the infant fontanelle, a well-established diagnostic marker for infections.
Founded by Javier Jimenez, PhD, MBA and CEO of the company after his participation in the M+Visión program, an initiative of the Madri+d Foundation and the Massachusetts Institute of Technology (MIT) to leverage the biomedical industry in the Regional Government of Madrid. Madrid-MIT M+Visión researchers are selected from all over the world to form multinational and multicultural teams to generate technology-based ideas that solve unmet medical needs. The startup was launched in 2015 with the desire to revolutionize the field of medical devices for non-invasive monitoring and screening of infant meningitis.
Upon request from key opinion leaders, the device is also being tested to show clinical feasibility in other applications of infections in serous body fluids. The company is also developing predictive models exploiting clinical, blood and the non-invasive cerebrospinal fluid white blood cells count to further support diagnostic and treatment decisions. Today a growing team, Newborn Solutions is attracting talent as our activities keep on flourishing and has established itself at the heart of the Barcelona Science Park, where research and innovation thrives.
We are regularly recognized and given support by distinguished industry, clinical peers, and institutions. We also gladly take part as a showcase of innovation in the healthcare and MedTech startup ecosystem in Spain and Europe, whenever the opportunity arises.